Finland - finska - Fimea (Suomen lääkevirasto)

aj vaccines a/s - poliovirus type 2 (mef-1), inactivated, poliovirus type 3 (saukett), inactivated, poliovirus type 1 (brunhilde), inactivated - injektioneste, liuos, esitäytetty ruisku - inaktivoitu poliorokote

Finland - finska - Fimea (Suomen lääkevirasto)

sanofi pasteur europe - poliovirus type 1 (mahoney), inactivated,bordetella pertussis fimbriae, adsorbed,haemophilus influenzae b polysaccharide,tetanus toxoid conjugate,clostridium tetani toxoid, adsorbed,bordetella pertussis toxoid, adsorbed,poliovirus type 3 (saukett), inactivated,bordetella pertussis filamentous haemagglutinin, adsorbed,bordetella pertussis pertactin, adsorbed,corynebacterium diphtheriae toxoid, adsorbed,poliovirus type 2 (mef-1), inactivated - injektioneste, suspensio, esitäytetty ruisku - kurkkumätä-, haemophilus influenzae tyyppi b -, hinkuyskä-, polio-, jäykkäkouristusrokote

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - leptospira interrogans serovar grippotyphosa, inactivated, leptospira interrogans serovar canicola, inactivated, leptospira interrogans serovar icterohaemorrhagiae, inactivated - injektioneste, suspensio - leptospiirarokote

Finland - finska - Fimea (Suomen lääkevirasto)

sanofi pasteur europe - influenza a virus h3n2, split virion, inactivated, influenza a virus h1n1, split virion, inactivated, influenza b virus, split virion, inactivated, victoria lineage, influenza b virus, split virion, inactivated, yamagata lineage - injektioneste, suspensio, esitäytetty ruisku - influenssarokote

Finland - finska - Fimea (Suomen lääkevirasto)

filavie - rhdv, inactivated, strain lp.sv.2012 (variant 2010, rhdv2), rhdv, inactivated, classical strain im507.sc.2011 - injektioneste, suspensio

Finland - finska - Fimea (Suomen lääkevirasto)

united vaccines holding b.v. - clostridium botulinum type c toxoid, pseudomonas aeruginosa -bacteria, serotype 5, inactivated, mink enteritis virus type ii, inactivated, mink enteritis virus type i, inactivated, pseudomonas aeruginosa bacteria, serotype 6, inactivated, pseudomonas aeruginosa bacteria, serotypes 7-8, inactivated - injektioneste, suspensio - minkin enteriittivirus - / parvovirus - + inaktivoitu klostridirokote + inaktivoitu pseudomonas -rok

Finland - finska - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - influenza b virus, split virion, inactivated, victoria lineage, influenza a virus h1n1, split virion, inactivated, influenza b virus, split virion, inactivated, yamagata lineage, influenza a virus h3n2, split virion, inactivated - injektioneste, suspensio, esitäytetty ruisku - influenssarokote

Finland - finska - Fimea (Suomen lääkevirasto)

laboratorios hipra s.a. - mannheimia haemolytica, leukotoxoid, serotype a1, inactivated, histophilus somni, bailie strain, inactivated - injektioneste, emulsio

Europeiska unionen - finska - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiset suidaeille - siat (lihotus) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Finland - finska - Fimea (Suomen lääkevirasto)

intervet international b.v. - clostridium perfringens beta toxoid, type b, clostridium perfringens beta toxoid, type c, clostridium perfringens epsilon toxoid, type d, clostridium septicum toxoid, clostridium novyi toxoid, clostridium chavoei bacterium (inactivated) and toxoid, clostridium perfringens type a alpha toxoid, clostridium tetani toxoid, clostridium sordellii toxoid, clostridium haemolyticum toxoid - injektioneste, suspensio - klostridirokote